Technology map
13AST technologies mapped
Sort the field
We evaluated platform features and classified them into three types.
Case Study · Technology Scouting
Speeding up antimicrobial testing directly from blood.
A global medical technology company wanted to find rapid antimicrobial susceptibility testing (AST) technologies that could shorten the time to identify a bacterial infection. We mapped the field and found an open niche for a new product.
The Client
The client is a global medical technology company looking for faster ways to determine the type of bacterial infection. It wanted rapid AST solutions that work directly from blood, on the market or close to it, and emerging ideas from academic labs.
The Challenge
Map the tests.
Find the opening.
Prescouter was asked to map rapid direct-from-blood AST technologies that were commercialized or close to commercialization, and to identify emerging technologies from academic research labs.
-
Commercial
Platforms on the market
Rapid AST systems sold today or close to launch.
-
Academic
Emerging lab methods
New approaches from university research groups.
-
AI and ML
Predicting resistance
Models that find resistance genes in genome data.
Our Approach
Mapping rapid AST through data, feedback, and AI research.
Solution scouting
10solutions highlighted
Look in the labs
We found two solutions from industry and eight from academic research groups.
Platform profiles
48rapid AST platforms
Profile the market
We profiled platforms and looked at AI and ML methods to predict antibiotic resistance genes.
The Outcome
An open niche for a new rapid AST product.
Prescouter profiled 48 rapid AST platforms and found that only a few focused on direct-from-blood testing, with little documented evidence of their species and antibiotic coverage. This gap presented a niche where the client could enter the space with a new rapid AST product.
-
Niche
Direct-from-blood testing
Few platforms serve it today.
-
Evidence
Coverage gaps
Little proof of species and antibiotic coverage.
-
Future
AI-based prediction
Resistance genes from whole genome sequencing data.
Every hour counts when a patient has a blood infection. Knowing where current tests fall short shows where a new product can help.
Let’s Talk
Where is the gap in your diagnostics market?
Map commercial and academic technologies and find the niche your next product can fill. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]